Biomarker: W006-IgE Mugwort

Overview

W006-IgE Mugwort measures serum allergen-specific immunoglobulin E (IgE) antibodies directed against mugwort pollen, usually Artemisia vulgaris. Mugwort pollen can trigger IgE-mediated allergic rhinitis, conjunctivitis, and asthma, particularly during its seasonal pollination period. A detectable result indicates sensitization to mugwort pollen, but it does not by itself confirm symptomatic allergy or predict reaction severity; interpretation requires the patient’s history and, when appropriate, other allergy tests. The test is clinically useful for identifying possible mugwort sensitization when evaluating seasonal respiratory or pollen-related allergic symptoms.

Clinical Use Cases

Evaluation of suspected mugwort-pollen allergic rhinitis, conjunctivitis, or asthma.
Identification of sensitization to mugwort when skin testing is unsuitable, unavailable, or affected by medications.
Assessment of patients with suspected weed-pollen allergy, including possible co-sensitization or cross-reactivity with ragweed and other pollens.
Supporting evaluation of pollen-food allergy syndromes associated with mugwort sensitization, particularly when clinical symptoms suggest reactions to plant foods.
Research into regional, seasonal, demographic, and molecular patterns of mugwort-specific IgE sensitization.

Specimen Types

Venous blood serum, the usual specimen for allergen-specific IgE testing.
Plasma may be accepted by some laboratory methods, depending on the assay and laboratory protocol.
Fresh or appropriately stored frozen serum may be used for some in-vitro immunoassays.

Measurement Methods

Fluorescence enzyme immunoassay, including quantitative allergen-specific IgE platforms such as ImmunoCAP.
Enzyme-linked immunosorbent assay, or ELISA.
Immunoblot or immunoblotting methods, primarily in research or component-allergen evaluation.
Multiplex allergen-specific IgE immunoassays that measure mugwort alongside other pollen allergens.
Component-resolved testing for mugwort allergens such as Art v 1, Art v 3, and other characterized components when clinically available.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergy blood test.
Patients should provide a complete list of prescription medicines, over-the-counter medicines, and supplements.
Antihistamines generally do not interfere with blood-based specific-IgE testing in the same way they can interfere with skin testing, but medication instructions may vary by test and laboratory.
Patients should not discontinue prescribed medicines unless instructed by a healthcare professional.
Results may be influenced by the assay platform, allergen extract composition, reporting units, and laboratory-specific reference ranges.
A positive result indicates sensitization, not necessarily clinically relevant allergy. Results should be interpreted with exposure history, symptom timing, physical findings, and other testing.
Cross-reactive antibodies to related weed pollens, profilins, polcalcins, or cross-reactive carbohydrate determinants may contribute to some positive results.
Mugwort pollen exposure is seasonal and geographically variable, so the timing and location of symptoms are relevant to interpretation.
Total IgE concentration, age, atopic disease, and other health conditions can affect the overall interpretation of IgE results, but they do not replace allergen-specific testing.